Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | RNA recognition motif domain containing protein | 0.0064 | 0.1475 | 0.144 |
Echinococcus multilocularis | smad | 0.0025 | 0.0356 | 0.0368 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0025 | 0.0356 | 0.0368 |
Schistosoma mansoni | smad | 0.0025 | 0.0356 | 0.0368 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0095 | 0.2364 | 0.2438 |
Plasmodium falciparum | nicotinamide/nicotinic acid mononucleotide adenylyltransferase | 0.0276 | 0.7532 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1475 | 0.1521 |
Schistosoma mansoni | smad1 5 8 and | 0.0025 | 0.0356 | 0.0368 |
Echinococcus granulosus | tar DNA binding protein | 0.0064 | 0.1475 | 0.1521 |
Mycobacterium ulcerans | bifunctional nicotinate-nucleotide adenylyltransferase NadD/hypothetical protein | 0.0276 | 0.7532 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0095 | 0.2364 | 0.2438 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0095 | 0.2364 | 0.2332 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0429 | 0.5 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0025 | 0.0356 | 0.0316 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0025 | 0.0356 | 0.0368 |
Brugia malayi | RNA binding protein | 0.0064 | 0.1475 | 0.144 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0429 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0064 | 0.1475 | 0.144 |
Schistosoma mansoni | hypothetical protein | 0.0352 | 0.9694 | 1 |
Echinococcus multilocularis | Smad4 | 0.0025 | 0.0356 | 0.0368 |
Brugia malayi | MH1 domain containing protein | 0.0025 | 0.0356 | 0.0316 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.0429 | 0.5 |
Echinococcus granulosus | geminin | 0.0352 | 0.9694 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0429 | 0.0389 |
Brugia malayi | MH2 domain containing protein | 0.0025 | 0.0356 | 0.0316 |
Treponema pallidum | hypothetical protein | 0.0276 | 0.7532 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0095 | 0.2364 | 0.2438 |
Schistosoma mansoni | smad1 5 8 and | 0.0025 | 0.0356 | 0.0368 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.2364 | 0.2438 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1475 | 0.1521 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0363 | 1 | 1 |
Plasmodium vivax | nicotinate-nucleotide adenylyltransferase, putative | 0.0276 | 0.7532 | 1 |
Schistosoma mansoni | Smad4 | 0.0025 | 0.0356 | 0.0368 |
Brugia malayi | MH1 domain containing protein | 0.0025 | 0.0356 | 0.0316 |
Schistosoma mansoni | hypothetical protein | 0.0352 | 0.9694 | 1 |
Mycobacterium leprae | PROBABLE NICOTINATE-NUCLEOTIDE ADENYLYLTRANSFERASE NADD (DEAMIDO-NAD(+) PYROPHOSPHORYLASE) (DEAMIDO-NAD(+) DIPHOSPHORYLASE) (NIC | 0.0276 | 0.7532 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0025 | 0.0356 | 0.0316 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1475 | 0.1521 |
Brugia malayi | TAR-binding protein | 0.0064 | 0.1475 | 0.144 |
Loa Loa (eye worm) | TAR-binding protein | 0.0064 | 0.1475 | 0.144 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.2364 | 0.2438 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0025 | 0.0356 | 0.0368 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0025 | 0.0356 | 0.0368 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1475 | 0.1521 |
Echinococcus granulosus | Smad4 | 0.0025 | 0.0356 | 0.0368 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.0429 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0363 | 1 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.0025 | 0.0356 | 0.0368 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0429 | 0.0389 |
Brugia malayi | Smad1 | 0.0025 | 0.0356 | 0.0316 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1475 | 0.1521 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0095 | 0.2364 | 0.2438 |
Echinococcus multilocularis | tar DNA binding protein | 0.0064 | 0.1475 | 0.1521 |
Loa Loa (eye worm) | Smad1 | 0.0025 | 0.0356 | 0.0316 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0064 | 0.1475 | 0.144 |
Mycobacterium tuberculosis | Probable nicotinate-nucleotide adenylyltransferase NadD (deamido-NAD(+) pyrophosphorylase) (deamido-NAD(+) diphosphorylase) (nic | 0.0276 | 0.7532 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0095 | 0.2364 | 0.2332 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0025 | 0.0356 | 0.0316 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.2364 | 0.2438 |
Brugia malayi | hypothetical protein | 0.0018 | 0.0153 | 0.0112 |
Echinococcus granulosus | smad | 0.0025 | 0.0356 | 0.0368 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0027 | 0.0429 | 0.5 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0025 | 0.0356 | 0.0368 |
Echinococcus multilocularis | geminin | 0.0352 | 0.9694 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Antibacterial activity against drug-resistant Escherichia coli clinical isolate assessed as inhibition zone diameter after 24 hrs by antibacterial susceptibility test | ChEMBL. | 18701299 | |
Activity (ADMET) | = 100 % | Cytotoxicity against human PBMC assessed as cell viability at 700 uM after 3 to 5 days by XTT method | ChEMBL. | 18701299 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.